User profiles for Winfried Randerath

Winfried Randerath

Professor der Medizin, Universität Köln
Verified email at klinik-bethanien.de
Cited by 9511

Non-CPAP therapies in obstructive sleep apnoea

WJ Randerath, J Verbraecken, S Andreas, G Bettega… - 2011 - Eur Respiratory Soc
In view of the high prevalence and the relevant impairment of patients with obstructive sleep
apnoea syndrome (OSAS) lots of methods are offered which promise definitive cures for or …

An individually adjustable oral appliance vs continuous positive airway pressure in mild-to-moderate obstructive sleep apnea syndrome

WJ Randerath, M Heise, R Hinz, KH Ruehle - Chest, 2002 - Elsevier
… Author links open overlay panel Winfried J. Randerath MD, FCCP a , Markus Heise DSD
b , Rolf Hinz DSD b , Karl-Heinz Ruehle MD a … Randerath W, Parys K, Lehmann D, et al. …

On the rise and fall of the apnea− hypopnea index: A historical review and critical appraisal

…, WT McNicholas, T Penzel, W Randerath… - Journal of sleep …, 2020 - Wiley Online Library
The publication of “The Sleep Apnea Syndromes” by Guilleminault et al. in the 1970s
hallmarked the discovery of a new disease entity involving serious health consequences. …

Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep

W Randerath, J Verbraecken, S Andreas… - European respiratory …, 2017 - Eur Respiratory Soc
The complexity of central breathing disturbances during sleep has become increasingly
obvious. They present as central sleep apnoeas (CSAs) and hypopnoeas, periodic breathing …

Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry

…, C Grohé, H Wilkens, W Randerath… - European …, 2015 - Eur Respiratory Soc
After introduction of the new international guidelines on idiopathic pulmonary fibrosis (IPF)
in 2011, we investigated clinical management practices for patients with IPF according to …

Non-CPAP therapies in obstructive sleep apnoea: mandibular advancement device therapy

…, J Verbraecken, W Randerath - European Respiratory …, 2012 - Eur Respiratory Soc
Mandibular advancement devices (MADs) represent the main non-continuous positive airway
pressure (non-CPAP) therapy for patients with obstructive sleep apnoea (OSA). The aim of …

[HTML][HTML] A novel extracorporeal CO2 removal system: results of a pilot study of hypercapnic respiratory failure in patients with COPD

…, H Teschler, F Bonin, H Becker, WJ Randerath… - Chest, 2013 - Elsevier
Background Hypercapnic respiratory failure in patients with COPD frequently requires
mechanical ventilatory support. Extracorporeal CO 2 removal (ECCO 2 R) techniques have not …

[HTML][HTML] European Respiratory Society guideline on non-CPAP therapies for obstructive sleep apnoea

W Randerath, J Verbraecken… - European …, 2021 - Eur Respiratory Soc
Treatment of obstructive sleep apnoea (OSA) in adults is evolving, as new therapies have
been explored and introduced in clinical practice, while other approaches have been refined …

Challenges and perspectives in obstructive sleep apnoea: report by an ad hoc working group of the Sleep Disordered Breathing Group of the European Respiratory …

W Randerath, CL Bassetti… - European respiratory …, 2018 - Eur Respiratory Soc
Obstructive sleep apnoea (OSA) is a major challenge for physicians and healthcare systems
throughout the world. The high prevalence and the impact on daily life of OSA oblige …

[HTML][HTML] K-ras mutation subtypes in NSCLC and associated co-occuring mutations in other oncogenic pathways

…, J Lorenz, I Sauerland, W Randerath… - Journal of Thoracic …, 2019 - Elsevier
Introduction Although KRAS mutations in NSCLC have been considered mutually exclusive
driver mutations for a long time, there is now growing evidence that KRAS-mutated NSCLC …